Analysis of galanin receptor GALR2 in multiple sclerosis

Pharmacogenomics J. 2019 Dec;19(6):499-500. doi: 10.1038/s41397-019-0100-6. Epub 2019 Oct 14.

Authors

Mary Encarnacion¹, Cecily Q Bernales¹, Anthony L Traboulsee², A Dessa Sadovnick^{1

2}, Carles Vilariño-Güell³

Affiliations

¹ Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
² Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
³ Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada. carles@can.ubc.ca.

PMID: 31611593
DOI: 10.1038/s41397-019-0100-6

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Female
Galanin / genetics*
Humans
Male
Middle Aged
Multiple Sclerosis / genetics*
Mutation / genetics
Receptor, Galanin, Type 2 / genetics*
Signal Transduction / genetics

Substances

Receptor, Galanin, Type 2
Galanin

Grants and funding

MOP-137051/CIHR/Canada